503 related articles for article (PubMed ID: 27523972)
1. Molecular Pathogenesis and Diagnostic, Prognostic and Predictive Molecular Markers in Sarcoma.
Mariño-Enríquez A; Bovée JV
Surg Pathol Clin; 2016 Sep; 9(3):457-73. PubMed ID: 27523972
[TBL] [Abstract][Full Text] [Related]
2. GLI1 Immunohistochemistry Distinguishes Mesenchymal Neoplasms With GLI1 Alterations From Morphologic Mimics.
Parrack PH; Mariño-Enríquez A; Fletcher CDM; Hornick JL; Papke DJ
Am J Surg Pathol; 2023 Apr; 47(4):453-460. PubMed ID: 36693363
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
[TBL] [Abstract][Full Text] [Related]
4. Advances in the Molecular Analysis of Soft Tissue Tumors and Clinical Implications.
Marino-Enriquez A
Surg Pathol Clin; 2015 Sep; 8(3):525-37. PubMed ID: 26297069
[TBL] [Abstract][Full Text] [Related]
5. Pleomorphic Sarcomas: The State of the Art.
Carvalho SD; Pissaloux D; Crombé A; Coindre JM; Le Loarer F
Surg Pathol Clin; 2019 Mar; 12(1):63-105. PubMed ID: 30709449
[TBL] [Abstract][Full Text] [Related]
6. Contemporary Sarcoma Diagnosis, Genetics, and Genomics.
Schaefer IM; Cote GM; Hornick JL
J Clin Oncol; 2018 Jan; 36(2):101-110. PubMed ID: 29220288
[TBL] [Abstract][Full Text] [Related]
7. [Detection of chromosomal abnormalities in soft tissue sarcomas: which sarcomas? Which abnormalities? How? Why?].
Genevay M; Gengler C; Guillou L
Bull Cancer; 2007 Sep; 94(9):781-92. PubMed ID: 17878098
[TBL] [Abstract][Full Text] [Related]
8. Molecular diagnostics in soft tissue sarcomas and gastrointestinal stromal tumors.
Smith SM; Coleman J; Bridge JA; Iwenofu OH
J Surg Oncol; 2015 Apr; 111(5):520-31. PubMed ID: 25772665
[TBL] [Abstract][Full Text] [Related]
9. [Molecular biology for sarcoma: useful or necessary?].
Neuville A; Coindre JM; Chibon F
Ann Pathol; 2015 Jan; 35(1):107-13. PubMed ID: 25533919
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical correlates of recurrent genetic alterations in sarcomas.
Anderson WJ; Hornick JL
Genes Chromosomes Cancer; 2019 Feb; 58(2):111-123. PubMed ID: 30382607
[TBL] [Abstract][Full Text] [Related]
11. [Molecular pathology of soft tissue tumors: Contribution to diagnosis and therapy prediction].
Schmitz K; Schildhaus HU
Pathologe; 2015 Mar; 36(2):126-36. PubMed ID: 25822596
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling for the investigation of soft tissue sarcoma pathogenesis and the identification of diagnostic, prognostic, and predictive biomarkers.
Beck AH; West RB; van de Rijn M
Virchows Arch; 2010 Feb; 456(2):141-51. PubMed ID: 19412622
[TBL] [Abstract][Full Text] [Related]
13. Sarcoma care in the era of precision medicine.
Wallander K; Öfverholm I; Boye K; Tsagkozis P; Papakonstantinou A; Lin Y; Haglund de Flon F
J Intern Med; 2023 Dec; 294(6):690-707. PubMed ID: 37643281
[TBL] [Abstract][Full Text] [Related]
14. Role of Next-Generation Sequencing as a Diagnostic Tool for the Evaluation of Bone and Soft-Tissue Tumors.
Szurian K; Kashofer K; Liegl-Atzwanger B
Pathobiology; 2017; 84(6):323-338. PubMed ID: 28817827
[TBL] [Abstract][Full Text] [Related]
15. Impact of molecular analysis on the final sarcoma diagnosis: a study on 763 cases collected during a European epidemiological study.
Neuville A; Ranchère-Vince D; Dei Tos AP; Montesco MC; Hostein I; Toffolatti L; Chibon F; Pissaloux D; Alberti L; Decouvelaere AV; Albert S; Rossi CR; Blay JY; Coindre JM
Am J Surg Pathol; 2013 Aug; 37(8):1259-68. PubMed ID: 23774173
[TBL] [Abstract][Full Text] [Related]
16. The past, present, and future of cytotoxic chemotherapy and pathway-directed targeted agents for soft tissue sarcoma.
Ryan CW; Desai J
Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714556
[TBL] [Abstract][Full Text] [Related]
17. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
[TBL] [Abstract][Full Text] [Related]
18. An evidence-based guideline on the application of molecular testing in the diagnosis, prediction of prognosis, and selection of therapy in non-GIST soft tissue sarcomas.
Yao X; Ghert M; Dickson BC; Popovic S; Purgina BM; Verma S; Werier J; Kandel RA
Cancer Treat Rev; 2020 Apr; 85():101987. PubMed ID: 32092619
[TBL] [Abstract][Full Text] [Related]
19. Molecular diagnosis of soft tissue neoplasia: clinical applications and recent advances.
Hameed M
Expert Rev Mol Diagn; 2014 Nov; 14(8):961-77. PubMed ID: 25109831
[TBL] [Abstract][Full Text] [Related]
20. Doing more with less: New markers for sarcoma diagnosis and their applicability to cytology specimens.
Dodd LG; Ware P; Duncan D; Hertel J
Diagn Cytopathol; 2016 Apr; 44(4):351-60. PubMed ID: 26780171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]